This month, we shine the spotlight on improving patient care for hematologic malignancies. As the largest Europe-based organization connecting hematologists worldwide, tune in this month to learn where you can go with #EHA: eha.fyi/join #BloodCancerAwarenessMonth

Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation? Abi V Stephanie Lee Grace Tang Tara Gomes Michelle Sholzberg buff.ly/4dmE6A7

This Labor Day, we recognize the hard work and dedication of all of our MD Anderson employees, including those working during the holiday weekend. #EndCancer

Did you know that as well as being #BloodCancerAwarenessMonth, September is host to 3 important awareness days? 🔴 #WorldLeukaemiaDay, 04/09 🔴 #WorldLymphomaDay, 15/09 🔴 #WorldCancerResearchDay, 24/09 Keep an eye on our socials to join the conversation.

Envision a world where every child with blood cancer thrives! ★彡 This #ChildhoodCancerAwarenessMonth, we’re daring to dream of a world with safer, more effective treatments for kids with blood cancer through The Dare to Dream Project. Together, we can improve the quality of

Horse: That's a really tiny horse. Dog: That's the biggest dog I've ever seen.

Myeloma Paper of the Day, September 2nd, suggested by Robert Z. Orlowski Ehsan Malek Amber Mosley oncodaily.com/insight/135351 #Cancer #MMSM #CancerResearch #Health #Medicine #MedTwitter #OncoDaily #Oncology

#Myeloma Paper of the Day: #Waldenström macroglobulinemia patients have impaired platelet and coagulation function, w/ plasma displaying slower thrombin generation & platelets contributing less to endogenous thrombin potential: pubmed.ncbi.nlm.nih.gov/39207869/. #mmsm

The Lung-MAP precision medicine trial’s S1900K sub-study randomizes patients w MET exon 14 skipping-positive advanced non-small cell #lungcancer to tepotinib w/wo ramucirumab. PI: Paul K. Paik, MD BenWellington. An ECOG-ACRIN Cancer Research Group sub-study. SWOG.org/clinical-trial… #NSCLC #lcsm

Just get him a football and he will be a Heisman winner. Gives the competition a great stiff paw ...

#Myeloma Paper of the Day: Mosaic chromosomal alterations in stem cell harvest product have no impact on outcomes in male patients getting ASCT, but female patients w/ X loss had longer OS, and multiple myeloma clones negatively impacted outcomes: pubmed.ncbi.nlm.nih.gov/39223296/. #mmsm

Today, NCI released its FY26 Annual Plan & Professional Judgment Budget Proposal—my first as NCI director. It outlines the funding needed to capitalize on scientific opportunities + advance our goal to #EndCancerAsWeKnowIt. Please read + share! go.nih.gov/8zYJsc9 #NCIFuture

.Lung-MAP S1900K is now enrolling patients with METex14-skipping #NSCLC. Hypothesis: resistance to MET inhibition in these patients is due to VEGFR2 signaling. Tests adding ramucirumab to MET inhibitor tepotinib. Co-PI: Xiuning Le MD PhD MD Anderson Cancer Center SWOG.org/clinical-trial…

During SOHO 2024 i had the privilege to visit with my mentor Dr Raymond Alexanian a physician legend who published in 1969 the combination of melphalan and prednisone ,the first effective regimen for multiple myeloma

Individuals who have slightly elevated M protein levels in their blood but do not have any symptoms & don't meet CRAB criteria may have one of two conditions that can lead to #myeloma. Watch our HIT Video on Precursor Conditions: ow.ly/NSrA50Tetmg #BloodCancerAwarenessMonth

#Myeloma Paper of the Day: Metformin augments GPRC5D expression in multiple myeloma and enhances the efficacy of GPRC5D-CAR T cells in pre-clinical in vitro models: pubmed.ncbi.nlm.nih.gov/39228074/. #mmsm

Don't miss Abstract Session 1 at #IMS24! Secure your spot today ➡️ rb.gy/1h136x

Robert Z. Orlowski We would like to inform you that your post has been successfully published on @Oncodaily. Thank you for sharing! oncodaily.com/insight/137075

#Myeloma Paper of the Day: Study of cancer incidence data from SEER22 cancer registry database w/ 10,183,928 total cases (2000-2020) finds young women have a faster average annual percentage change in myeloma vs. males: pubmed.ncbi.nlm.nih.gov/39232785/. #mmsm

Robert Z. Orlowski We would like to inform you that your post has been successfully published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/insight/137563